STEFAN BRADU, M.D.
Dermatology at Queens Blvd, Flushing, NY
License number
New York 2321771
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
10721 Queens Blvd, Flushing, NY 11375
Phone
(718) 541-0593
(718) 541-059x
(718) 541-059x
Personal information
See more information about STEFAN BRADU at radaris.comName
Address
Phone
8519 65Th Rd, Rego Park, NY 11374
120 Brenner Ave, Bethpage, NY 11714
4277 Hempstead Tpke, Bethpage, NY 11714
6321 Alderton St, Rego Park, NY 11374
Organization information
See more information about STEFAN BRADU at bizstanding.comDermatology & Aesthetics - Stefan Bradu MD
8519 65 Rd, Rego Park, NY 11374
Categories:
Dermatology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(718) 459-1493 (Phone)
Areas served:
Queens
Brands:
Restylane
Products:
Accepting New Patients, Acne Treatments, Adolescent Care, ...
Payment options:
Personal Checks
Certifications:
American Academy Of Dermatology, American Society For Dermatologic Surgery, Board Certified Dermatologist
Professional information
See more information about STEFAN BRADU at trustoria.com
Dr. Stefan Bradu, Forest Hills NY - MD (Doctor of Medicine)
Dr. Stefan Bradu, Forest Hills NY - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Dermatology & Aesthetics, P.C.
10721 Queens Blvd, Forest Hills 11375
(718) 459-1493 (Phone), (718) 520-7180 (Fax)
10721 Queens Blvd, Forest Hills 11375
(718) 459-1493 (Phone), (718) 520-7180 (Fax)
Certifications:
Dermatology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Dermatology & Aesthetics, P.C.
10721 Queens Blvd, Forest Hills 11375
NYU Langone Medical Center
550 1St Ave, New York 10016
Saint Joseph Hospital
4295 Hempstead Tpke, Bethpage 11714
10721 Queens Blvd, Forest Hills 11375
NYU Langone Medical Center
550 1St Ave, New York 10016
Saint Joseph Hospital
4295 Hempstead Tpke, Bethpage 11714
Education:
Medical School
SUNY Downstate Medical Center College Of Medicine
Graduated: 2001
SUNY Downstate Medical Center College Of Medicine
Graduated: 2001
Pancreatic Cancer Associated Antigen, Antibody Thereto, And Diagnostic And Treatment Methods
Pancreatic Cancer Associated Antigen, Antibody Thereto, And Diagnostic And Treatment Methods
US Patent:
2006025, Nov 16, 2006
Filed:
Jan 16, 2004
Appl. No.:
10/542239
Inventors:
Josef Michl - LITTLE NECK NY, US
Stefan Bradu - Rego Park NY, US
Raquib Hannan - East Meadow NY, US
Matthew Pincus - Brooklyn NY, US
Stefan Bradu - Rego Park NY, US
Raquib Hannan - East Meadow NY, US
Matthew Pincus - Brooklyn NY, US
International Classification:
C07K 14/82, C07K 16/30
US Classification:
530350000, 530388800
Abstract:
The present invention is directed to an antigen found on the surface of rat and human pancreatic cancer cells and provides antibodies of high specificity and selectivity to this antigen as well as hybridomas secreting the subject antibodies. Methods for both the diagnosis and treatment of pancreatic cancer are also provided. This tissue marker of pancreatic adenocarcinoma, an approximately 43.5 kD surface membrane protein designated PaCa-Ag1, is completely unexpressed in normal pancreas but abundantly expressed in pancreatic carcinoma cells. Moreover, a soluble form of PaCa-Ag1 exists, having a molecular weight about 36 to about 38 kD, that is readily identified in sera and other body fluids of pancreatic cancer patients, using a subject antibody.
Stefan Bradu, Bethpage NY
Stefan Bradu, Bethpage NY
Specialties:
Dermatology
Work:
Academic Dermatology
4277 Hempstead Tpke, Bethpage, NY 11714 Brooklyn Campus of the VA NY Harbor Healthcare System
800 Poly Pl, Brooklyn, NY 11209 Dermatology & Aesthetics, PC
6321 Alderton St, Rego Park, NY 11374
4277 Hempstead Tpke, Bethpage, NY 11714 Brooklyn Campus of the VA NY Harbor Healthcare System
800 Poly Pl, Brooklyn, NY 11209 Dermatology & Aesthetics, PC
6321 Alderton St, Rego Park, NY 11374
Education:
State University of New York Downstate (2001)
Tolerance-Induced Targeted Antibody Production
Tolerance-Induced Targeted Antibody Production
US Patent:
2007003, Feb 15, 2007
Filed:
Jan 29, 2004
Appl. No.:
10/542586
Inventors:
Josef Michl - Little Neck NY, US
Stefan Bradu - Rego Park NY, US
Stefan Bradu - Rego Park NY, US
International Classification:
A61K 39/00, C12P 21/04
US Classification:
424185100, 424277100, 435070210
Abstract:
The present invention provides methods for directing the immune response of an animal towards immunologically weak or rare antigens such as tumor antigens. The methods combine subtractive immunization with hyperimmunization and result in the controlled or directed production of target-specific antibodies, helper T cells (CD4-T lymphocytes) and cytotoxic T cells (CD8-T lymphocytes). Also provided by the present invention are untransformed and transformed cell lines, and growth media necessary to grow the untransformed cell line in a differentiated state. Monoclonal antibodies which react with different neoplastic cell lines and hybridomas producing such antibodies are also provided.